Alexander C. Small, Che-Kai Tsao, Erin L. Moshier, Benjamin A. Gartrell, Juan P. Wisnivesky, James H. Godbold, Cardinale B. Smith, Guru Sonpavde, William K. Oh and Matthew D. Galsky Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy Cancer 118
Version of Record online: 15 JUN 2012 | DOI: 10.1002/cncr.27658
Approximately 20% of patients who present with American Joint Committee on Cancer stage IV solid tumors do not receive anticancer therapy. Although it is likely that there are multiple reasons for a lack of treatment, the finding of potential disparities has implications with regard to health care policy and access to care.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field